The Gabrail Pharmacology Phase 1 Research Center — Canton, Ohio

The Gabrail Pharmacology Phase 1 Research Center is a clinical research site located in Canton, Ohio, United States 44718.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

The Gabrail Pharmacology Phase 1 Research Center has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Advanced Solid Tumor, Solid Tumor, Solid Tumor, Adult.

Sponsors: Xilio Development, Inc., NiKang Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Gabrail Pharmacology Phase 1 Research Center?

The Gabrail Pharmacology Phase 1 Research Center has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Gabrail Pharmacology Phase 1 Research Center conducted?

The Gabrail Pharmacology Phase 1 Research Center has 2 clinical trials on record, with 1 currently active. Their work covers Advanced Solid Tumor, Solid Tumor, Solid Tumor, Adult.

Is The Gabrail Pharmacology Phase 1 Research Center accredited by Crixeo Health?

The Gabrail Pharmacology Phase 1 Research Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The Gabrail Pharmacology Phase 1 Research Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.